{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:27:33Z","timestamp":1793330853319,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hypertension has been recognized as one of the highest risk factors for cardiovascular diseases. Anti-hypertension agent screening and development has been recognized as a pharmaceutical therapy approach for the cardiovascular diseases treatment. Many kinds of traditional Chinese medicines, such as pine needle, have been used for the treatment of hypertension for a long time, but the bioactive ingredients which responsible for their therapeutic effectiveness are remain unclear. Therefore, screening bioactive chemicals in natural sources is still the most straightforward strategy for novel Angiotensin-converting enzyme inhibitor (ACEi)-based anti-hypertension agents discovery. In this study, we demonstrated a bioactivity-guided fractionation strategy for identifying bioactive fractions and chemicals from pine needle based on LC\/MS assay as well as elucidating their mechanisms of pharmacological activity. And we found out the compound in pine needle extracts being ACE-inhibitory active is catechin. When ACE activity was assayed in rat tissue membranes, it was observed that catechin demonstrate ACE inhibition in kidney, lung and testes tissue. All these presents catechin in pine needle could be a potential cardiovascular medicine.<\/jats:p>","DOI":"10.1038\/s41598-017-07748-x","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T16:08:26Z","timestamp":1502726906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Bioactivity-Guided Fractionation of Pine Needle Reveals Catechin as an Anti-hypertension Agent via Inhibiting Angiotensin-Converting Enzyme"],"prefix":"10.1038","volume":"7","author":[{"given":"Jian","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,21]]},"reference":[{"key":"7748_CR1","doi-asserted-by":"crossref","unstructured":"Alissa, E. M. & Ferns, G. A. Functional foods and nutraceuticals in the primary prevention of cardiovascular diseases. J. Nutr Metab. 569486 (2012).","DOI":"10.1155\/2012\/569486"},{"key":"7748_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11906-004-0072-y","volume":"6","author":"F El-Atat","year":"2004","unstructured":"El-Atat, F., McFarlane, S. I. & Sowers, J. R. Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management. Curr Hypertens Rep. \n                           6, 215\u2013223 (2004).","journal-title":"Curr Hypertens Rep."},{"key":"7748_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pop.2012.11.008","volume":"40","author":"KH Winter","year":"2013","unstructured":"Winter, K. H., Tuttle, L. A. & Viera, A. J. Hypertension. Prim Care. \n                           40, 179\u2013194 (2013).","journal-title":"Prim Care."},{"key":"7748_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/HYPERTENSIONAHA.113.01063","volume":"62","author":"G Faraco","year":"2013","unstructured":"Faraco, G. & Iadecola, C. Hypertension: a harbinger of stroke and dementia. Hypertension. \n                           62, 810\u2013817 (2013).","journal-title":"Hypertension."},{"key":"7748_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1161\/HYPERTENSIONAHA.114.03617","volume":"65","author":"ZA Sun","year":"2015","unstructured":"Sun, Z. A. arterial stiffness, and hypertension. Hypertension. \n                           65, 252\u2013256 (2015).","journal-title":"Hypertension."},{"key":"7748_CR6","doi-asserted-by":"crossref","unstructured":"Ezzati, M. et al. Rethinking the \u201cdiseases of affluence\u201d paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med. e133 (2005).","DOI":"10.1371\/journal.pmed.0020133"},{"key":"7748_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/ajh\/2.8.659","volume":"2","author":"KK Griendling","year":"1989","unstructured":"Griendling, K. K., Tsuda, T., Berk, B. C. & Alexander, R. W. Angiotensin II stimulation of vascular smooth muscle cells. Secondary signalling mechanisms. Am J Hypertens. \n                           2, 659\u2013665 (1989).","journal-title":"Am J Hypertens."},{"key":"7748_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1440-1681.1988.tb01051.x","volume":"15","author":"KK Griendling","year":"1988","unstructured":"Griendling, K. K. et al. Secondary signalling mechanisms in angiotensin II-stimulated vascular smooth muscle cells. Clin Exp Pharmacol Physiol. \n                           15, 105\u2013112 (1988).","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"7748_CR9","first-page":"9","volume":"13","author":"SA Atlas","year":"2007","unstructured":"Atlas, S. A. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J. Manag Care Pharm. \n                           13, 9 (2007).","journal-title":"J. Manag Care Pharm."},{"key":"7748_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2165\/00003495-199958040-00006","volume":"58","author":"MD Fotherby","year":"1999","unstructured":"Fotherby, M. D. & Panayiotou, B. Antihypertensive therapy in the prevention of stroke: what, when and for whom? Drugs. \n                           58, 663 (1999).","journal-title":"Drugs."},{"key":"7748_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1742-6723.2011.01529.x","volume":"24","author":"HS Chuah","year":"2012","unstructured":"Chuah, H. S. & O\u2019Donnell, D. Angiotensin-converting enzyme inhibitor and visceral angio-oedema. Emerg Med Australas. \n                           24, 207\u2013208 (2012).","journal-title":"Emerg Med Australas."},{"key":"7748_CR12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.annepidem.2012.07.001","volume":"22","author":"KJ Mukamal","year":"2012","unstructured":"Mukamal, K. J., Ghimire, S., Pandey, R., Fiarman, G. S. & Gautam, S. Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis. Ann Epidemiol. \n                           22, 747\u201350 (2012).","journal-title":"Ann Epidemiol."},{"key":"7748_CR13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/MAJ.0b013e318258317f","volume":"344","author":"JL Kuhlen Jr.","year":"2012","unstructured":"Kuhlen, J. L. Jr. & Forcucci, J. Angiotensin-converting enzyme inhibitor-induced unilateral tongue angioedema. Am J Med Sci. \n                           344, 416\u2013417 (2012).","journal-title":"Am J Med Sci."},{"key":"7748_CR14","first-page":"4","volume":"29","author":"PM Thalanayar","year":"2014","unstructured":"Thalanayar, P. M., Ghobrial, I., Lubin, F., Karnik, R. & Bhasin, R. Drug-induced visceral angioedema. J Community Hosp Intern Med Perspect. \n                           29, 4 (2014).","journal-title":"J Community Hosp Intern Med Perspect."},{"key":"7748_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0378-8741(98)00201-3","volume":"65","author":"B Somanadhan","year":"1999","unstructured":"Somanadhan, B. et al. An ethnopharmacological survey for potential angiotensin converting enzyme inhibitors from Indian medicinal plants. J. Ethnopharmacol. \n                           65, 103 (1999).","journal-title":"J. Ethnopharmacol."},{"key":"7748_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0378-8741(97)00158-X","volume":"60","author":"U Nyman","year":"1998","unstructured":"Nyman, U. et al. Ethnomedical information and in vitro screening for angiotensin-converting enzyme inhibition of plants utilized as traditional medicines in Gujarat, Rajasthan and Kerala (India). J. Ethnopharmacol. \n                           60, 247 (1998).","journal-title":"J. Ethnopharmacol."},{"key":"7748_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0378-8741(99)00097-5","volume":"68","author":"AC Duncan","year":"1999","unstructured":"Duncan, A. C., Jager, A. K. & van Staden, J. Screening of Zulu medicinal plants for angiotensin converting enzyme (ACE) inhibitors. J. Ethnopharmacol. \n                           68, 63 (1999).","journal-title":"J. Ethnopharmacol."},{"key":"7748_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0378-8741(97)00100-1","volume":"58","author":"A Adsersen","year":"1997","unstructured":"Adsersen, A. & Adsersen, H. Plants from R\u00e9union Island with alleged antihypertensive and diuretic effects\u2013an experimental and ethnobotanical evaluation. J. Ethnopharmacol. \n                           58, 189 (1997).","journal-title":"J. Ethnopharmacol."},{"key":"7748_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1142\/S0192415X15500202","volume":"43","author":"J He","year":"2015","unstructured":"He, J. & Li, Y. L. Ginsenoside Rg1 downregulates the shear stress induced MCP-1 expression by inhibiting MAPK signaling pathway. Am J Chin Med. \n                           43, 305\u2013317 (2015).","journal-title":"Am J Chin Med."},{"key":"7748_CR20","first-page":"9888","volume":"10","author":"J He","year":"2011","unstructured":"He, J. et al. Effect of Mesima Reishi UE-1 on invasion of human ovarian cancer cells in vitro. Afr. J Biotech. \n                           10, 9888\u20139897 (2011).","journal-title":"J Biotech."},{"key":"7748_CR21","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.cell.2007.08.021","volume":"130","author":"TW Corson","year":"2007","unstructured":"Corson, T. W. & Crews, C. M. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell. \n                           130, 769\u2013774 (2007).","journal-title":"Cell."},{"key":"7748_CR22","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1021\/jm0704090","volume":"51","author":"DJ Newman","year":"2008","unstructured":"Newman, D. J. Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J. Med. Chem. \n                           51, 2589\u20132599 (2008).","journal-title":"J. Med. Chem."},{"key":"7748_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1126\/science.1168243","volume":"325","author":"JW Li","year":"2009","unstructured":"Li, J. W. & Vederas, J. C. Drug discovery and natural products: end of an era or an endless frontier? Science. \n                           325, 161\u2013165 (2009).","journal-title":"Science."},{"key":"7748_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/np200906s","volume":"75","author":"DJ Newman","year":"2012","unstructured":"Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. \n                           75, 311\u2013335 (2012).","journal-title":"J. Nat. Prod."},{"key":"7748_CR25","doi-asserted-by":"publisher","first-page":"e39782","DOI":"10.1371\/journal.pone.0039782","volume":"7","author":"F Zhu","year":"2012","unstructured":"Zhu, F. et al. Drug discovery prospect from untapped species: indications from approved natural product drugs. PLoS One. \n                           7, e39782 (2012).","journal-title":"PLoS One."},{"key":"7748_CR26","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.drudis.2009.06.010","volume":"14","author":"W Weber","year":"2009","unstructured":"Weber, W. & Fussenegger, M. The impact of synthetic biology on drug discovery. Drug Discovery Today. \n                           14, 956\u2013963 (2009).","journal-title":"Drug Discovery Today."},{"key":"7748_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrd3480","volume":"10","author":"DC Swinney","year":"2011","unstructured":"Swinney, D. C. & Anthony, J. How were new medicines discovered? Nat. Rev. Drug Discovery. \n                           10, 507\u2013519 (2011).","journal-title":"Nat. Rev. Drug Discovery."},{"key":"7748_CR28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/10408398.2010.550071","volume":"53","author":"WY Huang","year":"2013","unstructured":"Huang, W. Y., Davidge, S. T. & Wu, J. Bioactive natural constituents from food sources-potential use in hypertension prevention and treatment. Crit Rev Food Sci Nutr. \n                           53, 615\u2013630 (2013).","journal-title":"Crit Rev Food Sci Nutr."},{"key":"7748_CR29","doi-asserted-by":"crossref","unstructured":"Cushman, D. W., Cheung, H. S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochemical Pharmacology. 1637\u20131648 (1971).","DOI":"10.1016\/0006-2952(71)90292-9"},{"key":"7748_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0378-4347(93)80208-L","volume":"613","author":"MT Doig","year":"1993","unstructured":"Doig, M. T. & Smiley, J. W. Direct injection assay of angiotensin-converting enzyme by high-performance liquid chromatography using a shielded hydrophobic phase column. J. Chromatogr. \n                           613, 145 (1993).","journal-title":"J. Chromatogr."},{"key":"7748_CR31","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S0731-7085(98)00122-8","volume":"19","author":"AS Mehanna","year":"1999","unstructured":"Mehanna, A. S. & Dowling, M. Liquid chromatographic determination of hippuric acid for the evaluation of ethacrynic acid as angiotensin converting enzyme inhibitor. J. Pharm Biomed Anal. \n                           19, 967 (1999).","journal-title":"J. Pharm Biomed Anal."},{"key":"7748_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.chroma.2003.08.055","volume":"1020","author":"Van Elswijk","year":"2003","unstructured":"Van Elswijk et al. Rapid detection and identification of angiotensin-converting enzyme inhibitors by on-line liquid chromatography-biochemical detection, coupled to electrospray mass spectrometry. J. Chromatogr A. \n                           1020, 45 (2003).","journal-title":"J. Chromatogr A."},{"key":"7748_CR33","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00216-005-3305-2","volume":"382","author":"A Liesener","year":"2005","unstructured":"Liesener, A. & Karst, U. Monitoring enzymatic conversions by mass spectrometry: a critical review. Anal Bioanal Chem. \n                           382, 1451 (2005).","journal-title":"Anal Bioanal Chem."},{"key":"7748_CR34","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1161\/01.HYP.0000174601.30793.b1","volume":"46","author":"KM Elased","year":"2005","unstructured":"Elased, K. M., Cool, D. R. & Morris, M. Novel mass spectrometric methods for evaluation of plasma angiotensin converting enzyme 1 and renin activity. Hypertension. \n                           46, 953 (2005).","journal-title":"Hypertension."},{"key":"7748_CR35","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1161\/01.HYP.0000215588.38536.30","volume":"47","author":"KM Elased","year":"2006","unstructured":"Elased, K. M., Cunha, T. S., Gurley, S. B., Coffman, T. M. & Morris, M. New mass spectrometric assay for angiotensin-converting enzyme 2 activity. Hypertension. \n                           47, 1010 (2006).","journal-title":"Hypertension."},{"key":"7748_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/bfgp\/eln041","volume":"7","author":"MW Duncan","year":"2008","unstructured":"Duncan, M. W., Roder, H. & Hunsucker, S. W. Quantitative matrix-assisted laser desorption\/ionization mass spectrometry. Brief Funct. Genomic Proteomic. \n                           7, 355 (2008).","journal-title":"Brief Funct. Genomic Proteomic."},{"key":"7748_CR37","doi-asserted-by":"crossref","unstructured":"Pezzuto, J. M. Plant-derived anticancer agents. Biochem Pharmacol. 24; 53: 121\u2013133 (1997).","DOI":"10.1016\/S0006-2952(96)00654-5"},{"key":"7748_CR38","doi-asserted-by":"crossref","unstructured":"Chen, L. et al. Bioactivity-Guided Fractionation of an Antidiarrheal Chinese Herb Rhodiola kirilowii as Inhibitors of Cystic Fibrosis Transmembrane Conductance Regulator. PLoS One. 6; 10: e0119122 (2015).","DOI":"10.1371\/journal.pone.0119122"},{"key":"7748_CR39","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.lfs.2003.07.037","volume":"74","author":"X Liu","year":"2004","unstructured":"Liu, X. et al. Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients. Life Sci. \n                           74, 855\u2013862 (2004).","journal-title":"Life Sci."},{"key":"7748_CR40","first-page":"51","volume":"75","author":"IV Bakhtin","year":"2006","unstructured":"Bakhtin, I. V. et al. Efficiency of Siberian pine oil in complex treating of people ill with benign hypertension. Vopr Pitan. \n                           75, 51\u201353 (2006).","journal-title":"Vopr Pitan."},{"key":"7748_CR41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/HJH.0b013e3283186994","volume":"27","author":"CJ Kwak","year":"2009","unstructured":"Kwak, C. J. et al. Antihypertensive effect of French maritime pine bark extract (Flavangenol): possible involvement of endothelial nitric oxide-dependent vasorelaxation. J Hypertens. \n                           27, 92\u2013101 (2009).","journal-title":"J Hypertens."},{"key":"7748_CR42","first-page":"CD008294","volume":"4","author":"A Schoonees","year":"2012","unstructured":"Schoonees, A., Visser, J., Musekiwa, A. & Volmink, J. Pycnogenol\u00ae (extract of French maritime pine bark) for the treatment of chronic disorders. Cochrane Database Syst Rev. \n                           4, CD008294 (2012).","journal-title":"Cochrane Database Syst Rev."},{"key":"7748_CR43","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.foodchem.2009.05.080","volume":"118","author":"l Wronique","year":"2010","unstructured":"Wronique, l, Karine, R., Laure, T., Dominique, H. & Patrick, A. A HPLC-UV method for the determination of angiotensin I-converting enzyme (ACE) inhibitory activity. Food Chemistry. \n                           118, 870\u2013875 (2010).","journal-title":"Food Chemistry."},{"key":"7748_CR44","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/0006-2952(95)02038-1","volume":"50","author":"QC Meng","year":"1995","unstructured":"Meng, Q. C., Balcells, E., Dell\u2019Italia, L., Durand, J. & Oparil, S. Sensitive method for quantitation of angiotensin-converting enzyme (ACE) activity in tissue. Biochem. Pharmacol. \n                           50, 1445\u20131450 (1995).","journal-title":"Biochem. Pharmacol."},{"key":"7748_CR45","first-page":"486","volume":"50","author":"NH Anaizi.","year":"1993","unstructured":"Anaizi., N. H. & Swenson, C. Instability of aqueous Captopril solutions. American Journal of Hospital Pharmacy. \n                           50, 486\u2013488 (1993).","journal-title":"American Journal of Hospital Pharmacy."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07748-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07748-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07748-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T09:04:04Z","timestamp":1671786244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07748-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["7748"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-07748-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,21]]},"assertion":[{"value":"18 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8867"}}